COPD is not a complex disease, Polverino explains. It's only complex to treat because of limited understanding.
Francesca Polverino, MD, PhD
Advertisement
ALA Spokesperson and professor at Baylor College of Medicine.
Articles by Francesca Polverino, MD, PhD
Polverino stresses the need for prospective analysis to validate CC16 and mucus plugs as viable biomarkers for COPD status.
This special episode of Lungcast features Harold P. Wimmer, CEO of the ALA, and Francesca Polverino, MD, PhD, an ALA spokesperson.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
SimpleScreen CRC Blood Test Meets Endpoints in Clinical Validation Study
2
Liver Lineup: Bepirovirsen and the Push Toward Functional Cure in Hepatitis B
3
Eplontersen Misses Primary Endpoint in Phase 3 ATTR-CM Trial
4
Biologic Therapy for Asthma and COPD: Real-World Perspectives From APPs
5